CNS Pharmaceuticals, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
CNS Pharmaceuticals, Inc. (CNSP) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$2.56 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-03-31
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-12-31 was -$2.56K.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-09-30 was $0.00.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-06-30 was $0.00.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2025 was -$2.56K, a 1446.84% decline from fiscal 2024.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was $190.00.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$498.00.
- CNS Pharmaceuticals, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$3.11K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$2.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.56K derived: sum of 2 quarters · filed 2026-03-31 | -$2.56K derived: sum of 3 quarters · filed 2026-03-31 | -$2.56K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $190.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $190.00 10-Q · filed 2025-11-14 | $449.00 derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $190.00 10-Q · filed 2025-08-14 | $449.00 derived: sum of 3 quarters · filed 2025-08-14 | -$308.00 derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $190.00 10-Q · filed 2025-05-15 | $449.00 derived: sum of 2 quarters · filed 2025-05-15 | -$308.00 derived: sum of 3 quarters · filed 2025-05-15 | -$308.00 derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $259.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$498.00 derived: sum of 2 quarters · filed 2025-03-31 | -$498.00 derived: sum of 3 quarters · filed 2025-03-31 | -$498.00 10-K · filed 2025-03-31 |
| 2023-09-30 | -$757.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$757.00 derived: sum of 2 quarters · filed 2024-11-14 | -$757.00 10-Q · filed 2024-11-14 | -$1.23K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | -$476.00 derived: sum of 3 quarters · filed 2024-08-14 | -$1.64K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | -$476.00 derived: sum of 2 quarters · filed 2024-05-15 | -$1.64K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$476.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.64K derived: sum of 2 quarters · filed 2024-04-01 | -$3.11K 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$1.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.63K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$1.47K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | -$1.58K 10-K · filed 2022-03-03 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |